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Foreword
As the largest organ of the body, the skin performs multiple critical functions, such as 
serving as the primary barrier to the external environment. For this reason, the skin is 
often exposed to potentially hazardous agents, including chemicals, which may contribute 
to the onset of a spectrum of adverse health effects ranging from localized damage (e.g., 
irritant contact dermatitis and corrosion) to induction of immune-mediated responses 
(e.g., allergic contact dermatitis and pulmonary responses), or systemic toxicity (e.g., 
neurotoxicity and hepatoxicity). Understanding the hazards related to skin contact with 
chemicals is a critical component of modern occupational safety and health programs.
In 2009, the National Institute for Occupational Safety and Health (NIOSH) pub-
lished Current Intelligence Bulletin (CIB) 61: A Strategy for Assigning New NIOSH Skin 
Notations [NIOSH 2009–147]. This document provides the scientific rationale and 
framework for the assignment of multiple hazard-specific skin notations (SK) that 
clearly distinguish between the systemic effects, direct (localized) effects, and immune- 
mediated responses caused by skin contact with chemicals. The key step within assign-
ment of the hazard-specific SK is the determination of a substance’s hazard potential, or 
its potential for causing adverse health effects as a result of skin exposure. This determi-
nation entails a health hazard identification process that involves use of the following:
 • Scientific data on the physicochemical properties of a chemical
 • Data on human exposures and health effects
 • Empirical data from in vivo and in vitro laboratory testing
 • Computational techniques, including predictive algorithms and mathematical 
models that describe a selected process (e.g., skin permeation) by means of ana-
lytical or numerical methods. 
This Skin Notation Profile provides the SK assignment and supportive data for 
2- ethoxyethanol (EE; CAS No. 110–80–5). In particular, this document evaluates and 
summarizes the literature describing the substance’s hazard potential and its assess-
ment according to the scientific rationale and framework outlined in CIB 61. In meet-
ing this objective, this Skin Notation Profile intends to inform the audience—mostly 
occupational health practitioners, researchers, policy- and decision-makers, employers, 
and workers in potentially hazardous workplaces—so that improved risk-management 
practices may be developed to better protect workers from the risks of skin contact with 
the chemical of interest. 
John Howard, M.D. 
Director, National Institute for  
 Occupational Safety and Health 
Centers for Disease Control and Prevention
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Abbreviations
ACGIH American Conference of Governmental Industrial Hygienists 
CIB Current Intelligence Bulletin
cm2 square centimeter(s)
cm/hr centimeter(s) per hour
DEREK™ Deductive Estimation of Risk from Existing Knowledge
DIR skin notation indicating the potential for direct effects to the skin 
following contact with a chemical
EC European Commission 
EE 2-ethoxyethanol
g/kg gram(s) per kilogram body weight 
GHS Globally Harmonized System of Classification and Labeling of Chemicals
GPMT guinea pig maximization test
IARC International Agency for Research on Cancer
IPCS International Program for Chemical Safety 
IUCID International Uniform Chemical Information Database
Kaq  coefficient in the watery epidermal layer 
Kp skin permeation coefficient 
Kpol  coefficient in the protein fraction of the stratum corneum
Kpsc  permeation coefficient in the lipid fraction of the stratum corneum 
LD50  dose resulting in 50% mortality in the exposed population
LDLo dermal lethal dose
LOAEL lowest-observed-adverse-effect level 
log KOW base-10 logarithm of a substance’s octanol–water partition
m3 cubic meter(s)
mg milligram(s)
mg/cm2/hr  milligram(s) per square centimeter per hour
mg/kg milligram(s) per kilogram body weight
mg/m3 milligram(s) per cubic meter
mL milliliter(s)
MW molecular weight
NIOSH National Institute for Occupational Safety and Health
NTP National Toxicology Program
OEL occupational exposure limit
OSHA Occupational Safety and Health Administration
REL recommended exposure limit
RF retention factor 
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SEN skin notation indicating the potential for immune-mediated reactions 
following exposure of the skin
SI ratio ratio of skin dose to inhalation dose
SK skin notation
SW  solubility 
SYS skin notation indicating the potential for systemic toxicity following 
exposure of the skin
USEPA United States Environmental Protection Agency 
viii Skin Notation Profiles | 2-Ethoxyethanol (EE)
Glossary 
Absorption—The transport of a chemical from the outer surface of the skin into both 
the skin and systemic circulation (including penetration, permeation, and resorption). 
Acute exposure—Contact with a chemical that occurs once or for only a short period 
of time. 
Cancer—Any one of a group of diseases that occurs when cells in the body become 
abnormal and grow or multiply out of control. 
Contaminant—A chemical that is (1) unintentionally present within a neat substance 
or mixture at a concentration less than 1.0% or (2) recognized as a potential carcinogen 
and present within a neat substance or mixture at a concentration less than 0.1%. 
Cutaneous (or percutaneous)—Referring to the skin (or through the skin). 
Dermal—Referring to the skin. 
Dermal contact—Contact with (touching) the skin. 
Direct effects—Localized, non-immune-mediated adverse health effects on the skin, 
including corrosion, primary irritation, changes in skin pigmentation, and reduction/
disruption of the skin barrier integrity, occurring at or near the point of contact with 
chemicals. 
Immune-mediated responses—Responses mediated by the immune system, including 
allergic responses. 
Sensitization—A specific immune-mediated response that develops following expo-
sure to a chemical, which, upon re-exposure, can lead to allergic contact dermatitis 
(ACD) or other immune-mediated diseases such as asthma, depending on the site and 
route of re-exposure. 
Substance—A chemical. 
Systemic effects—Systemic toxicity associated with skin absorption of chemicals after 
exposure of the skin.
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1.2 Purpose 
This Skin Notation Profile presents (1) a 
brief summary of technical data associat-
ed with skin contact with EE and (2) the 
rationale behind the hazard-specific skin 
notation (SK) assignment for EE. The SK 
assignment is based on the scientific ra-
tionale and logic outlined in the Current 
Intelligence Bulletin (CIB) 61: A Strategy 
for Assigning New NIOSH Skin Notations 
[NIOSH 2009]. The summarized infor-
mation and health hazard assessment are 
limited to an evaluation of the potential 
health effects of dermal exposure to EE. 
A literature search was conducted through 
July 2010 to identify information on EE, 
including but not limited to data relating 
to its toxicokinetics, acute toxicity, repeat-
ed-dose systemic toxicity, carcinogenicity, 
biological system/function–specific effects 
(including reproductive and developmen-
tal effects and immunotoxicity), irritation, 
and sensitization. Information was con-
sidered from studies of humans, animals, 
or appropriate modeling systems that are 
relevant to assessing the effects of dermal 
exposure to EE. 
1.3 Overview of SK Assignment for EE
EE is potentially capable of causing mul-
tiple toxic effects following skin contact. 
A critical review of available data has re-
sulted in the following SK assignment for 
EE: SK: SYS. Table 1 provides an over-
view of the critical effects and data used to 
develop the SK assignment for EE. 
2 Systemic Toxicity from Skin 
Exposure (SK: SYS)
Toxicokinetic studies following dermal 
exposure to EE were identified. In a study 
involving healthy volunteers, Kezic et al. 
[1997] noted that vaporized and liquid 
EE were readily absorbed, with uptake 
through the skin estimated to be 42% fol-
lowing a 45-minute combined inhalation 
and dermal exposure (with the assump-
tion that the whole body surface was ex-
posed to vapor). Those investigators re-
ported permeability coefficients (Kp) of 
19 centimeters per hour (cm/hr) follow-
ing dermal exposure of an area of 1000 
square centimeter (cm2) on the forearm 
and hand to the vapor for 45 minutes and 
1 Introduction




EE; 2-EE; EGEE; Ethylene Glycol 
Mzonoethyl Ether; Ethyl Cello-
solve; Ethylglycol




2-Ethoxyethanol (EE) is an organic 
compound used primarily as a chemi-
cal intermediate and solvent [Boatman 
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0.7 milligrams per square centimeter per 
hour (mg/cm2/hr) when an area of 27 cm2 
(forearm) was exposed to the liquid for 
15 minutes. Lockley et al. [2002] report-
ed absorption of 8% of the administered 
dose in human skin in vitro. Larese Filon 
et al. [1999] and Wilkinson and Williams 
[2002] also reported a high potential for 
skin absorption of EE in vitro by human 
skin or by full-thickness or dermatomed 
human breast skin. A dermal in vitro pen-
etration rate of 0.80 mg/cm2/hr has been 
measured experimentally in human skin 
[Dugard 1984; Larese Filon et al. 1999]. 
In rats, Sabourin et al. [1992] noted dermal 
absorption of approximately 20% to 27% 
of the nonocclusive administered dose. 
Lockley et al. [2002] reported absorption 
of 25% of the dose when radiolabeled EE 
was administered to occluded rat skin in 
vivo. When administered in vitro to split 
rat skin, absorption was 22% under oc-
clusion and 20% without occlusion. The 
study by Lockley et al. [2002] indicated 
that the in vitro rat results most accurately 
predicted absorption through rat skin in 
vivo and that penetration through rat skin 
was greater than through human skin in 
vitro. The investigators also noted that sys-
temic exposure after skin contact is likely 
to be to the parent material. By extrapola-
tion of the in vitro data for human and rat 
skin, Lockley et al. [2002] suggested that 
the dermal absorption of EE at the same 
dose in humans would be approximately 
one-third of that in rats in vivo. The avail-
able absorption data demonstrate that the 
substance is systemically available follow-
ing dermal exposure in humans. 
The potential of EE to pose a skin absorp-
tion hazard was also evaluated by means of 
a predictive algorithm for estimating and 
evaluating the health hazards of dermal 
exposure to substances [NIOSH 2009]. 
The evaluation method compares an esti-
mated chemical dose accumulated in the 
body from skin absorption and an estimat-
ed dose from respiratory absorption asso-
ciated with a reference occupational expo-
sure limit. On the basis of this algorithm, a 
ratio of the skin dose to the inhalation dose 
(SI ratio) of 132.66 was calculated for EE. 
An SI ratio of ≥0.1 indicates that a chemi-
cal is capable of producing systemic tox-
icity from skin exposure [NIOSH 2009]. 
Additional information on the SI ratio and 
the variables used in its calculation are in-
cluded in the appendix.
No information was identified regarding 
acute toxicity of EE in humans following 
dermal exposure. However, with regard to 
animals, the dermal LD50 value (the dose 
resulting in 50% mortality in the exposed 
population) for rabbits was 3900 mil-
ligrams per kilogram body weight (mg/
kg) under occlusive conditions in one 
study [Daughtrey et al. 1984] and ranged 
from 2511 mg/kg to 4950 mg/kg in an-
other [Eastman Kodak Company 1992]. 
Because the reported acute dermal LD50 
value for the rabbit is greater than the 
critical dermal LD50 value of 2000 mg/
kg body weight that identifies a chemi-
cal substance with the potential for acute 
dermal toxicity [NIOSH 2009], EE is not 
considered to be systemically toxic by the 
acute dermal route.
Table 1. Summary of the SK assignment for EE
Skin notation Critical effect Data available
SK: SYS Teratogenicity, develop-
mental toxicity,
reproductive toxicity
Limited human and animal data
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No data regarding the health effects 
caused by chronic or subchronic dermal 
exposures to EE in humans were identi-
fied. A series of cross-sectional and en-
vironmental studies were identified that 
investigated occupational exposures of 
shipyard painters to EE and other glycol 
ethers [Sparer et al. 1988; Welch and Cul-
len 1988; Welch et al. 1988]. In the first 
study, Welch and Cullen [1988] reported 
various hematological effects (i.e., anemia, 
granulocytopenia, and low polymorpho-
nuclear leukocyte count) among exposed 
workers. Welch et al. [1988] indicated that 
male workers experienced effects of the 
reproductive system, including increased 
frequency of reduced sperm counts and 
decreased testicular size. Those studies 
provided estimates of airborne concentra-
tions of glycol ether compounds includ-
ing EE. Despite providing no estimates of 
dermal exposures, the authors concluded 
that skin contact was a significant expo-
sure pathway for glycol ethers. It should 
also be noted that the adverse effects noted 
in the studies cannot be exclusively linked 
to EE and do not provide evidence that 
glycol ethers may cause systemic toxicity 
that target the male reproductive system 
and the hematological system. 
Dermal repeated-dose toxicity stud-
ies [Hardin et al. 1982, 1984; Ryan et al. 
1988] in animals indicate that EE induced 
adverse teratogenic, developmental, and 
reproductive effects. Hardin et al. [1982] 
observed a significant increase in resorp-
tions, significant decrease in number of 
live fetuses per litter, significant decrease in 
fetal body weight, and significant increase 
in the incidence of visceral malformations 
(predominantly of the cardiovascular sys-
tem) and skeletal variations in rats der-
mally exposed four times per day to 0.25 
or 0.50 milliliter (mL) applications of EE 
(corresponding to 1 mL/day or 2 mL/day) 
during gestation days 7 to 16, followed by 
a 5-day postexposure period. The Inter-
national Uniform Chemical Information 
Database (IUCID) [ECB 2000] reported 
the doses as 3445 milligram per kilogram 
body weight per day (mg/kg/day) and 
6889 mg/kg/day. Because maternal tox-
icity (ataxia toward the end of the treat-
ment period and a significant decrease 
in body weight gain in the last half of 
gestation) was observed only at the high 
dose, a LOAEL of 3445 mg/kg/day for 
developmental effects can be established 
in the absence of maternal toxicity. In a 
later teratogenicity study by Hardin et al. 
[1984], in which EE was used as a positive 
control in rats, dermal application of 0.25 
mL of EE four times daily—reported as 
3875 mg/kg/day [ECB 2000]—on gesta-
tion days 7 to 16 resulted in similar toxic-
ity; manifestations were a decrease in body 
weight in dams associated with complete-
ly resorbed litters, a significant decrease in 
fetal body weights, and a significant in-
crease in visceral malformations and skel-
etal variations, in comparison with nega-
tive control animals. EE was also used as 
a positive control in another dermal tera-
togenicity study. In that study, conducted 
by Ryan et al. [1988], EE caused devel-
opmental effects, as evidenced by reduced 
fetal body weight, cardiovascular defects, 
delayed skeletal development, and skeletal 
malformations in rats when 0.1 mL of the 
chemical (calculated to be equivalent to 
93 mg/kg/day) was applied to the skin on 
gestation days 6 to 15. The developmental 
studies available demonstrate that EE is a 
dermal teratogen and that a developmen-
tal LOAEL of 93 mg/kg/day [Ryan et al. 
1988] can be established for the chemical. 
No long-term study, standard reproductive 
toxicity study, or specialty studies evaluat-
ing function-specific effects (including re-
productive toxicity and immunotoxicity) 
or carcinogenicity study following dermal 
exposure to EE was identified. Table 2 
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provides a summary of carcinogenic des-
ignations from multiple governmental and 
nongovernmental organizations for EE. 
Review of available data indicates that EE 
is absorbed, systemically available, and po-
tentially toxic. In particular, the reviewed 
studies provide sufficient evidence to deter-
mine that EE may cause teratogenic, de-
velopmental, and reproductive effects fol-
lowing repeated skin contact [Hardin et al. 
1982, 1984; Ryan et al. 1988*]. Therefore, 
on the basis of the data for this assessment, 
EE is not assigned the SK: SYS notation.
3 Direct Effects on Skin (SK: DIR)
No data on corrosivity of EE or in vitro tests 
for corrosivity with human or animal skin 
models or for skin integrity with cadaver 
skin were identified. Skin irritation studies 
produced inconsistent results, depending on 
the standard protocol used in assessing the 
irritation potential. EE applied under an oc-
clusive wrap to depilated abdominal skin of 
rabbits at doses up to 3.8 grams per kilogram 
(g/kg) and to guinea pigs at doses up to 18.6 
*References in bold text indicate studies that served 
as the basis of the SK assignment.
g/kg for 24 hours produced only slight ir-
ritation, according to the Draize scale [East-
man Kodak Company 1981, 1992]. Zissu 
[1995] reported EE to be nonirritating to 
rabbits after using the European Economic 
Community (EEC) test method, but the 
investigator did not evaluate this chemical 
with the Draize protocol of 24 hours versus 
4 hours occlusion, as in the EEC method. 
The structure activity relationship model, 
Deductive Estimation of Risk from Exist-
ing Knowledge (DEREK™) for Windows, 
predicted EE to be a skin irritant.
The available information demonstrates 
that EE produces only a very mild skin 
irritation at very high doses or following 
prolonged and repeated dermal exposure. 
Therefore, on the basis of the data for this 




No evidence of the potential of EE to 
cause skin sensitization in humans has 
been identified. Zissu [1995] did not ob-
serve delayed cutaneous hypersensitivity 
(i.e., cell-mediated sensitization) in the 
Table 2. Summary of the carcinogenic designations* for EE by  numerous 
 governmental and nongovernmental organizations







Abbreviations: ACGIH = American Conference of Governmental Industrial Hygienists; EC = European Commission, Joint Re-
search, Institute for Health and Consumer Protection; IARC = International Agency for Research on Cancer; NIOSH = National 
Institute for Occupational Safety and Health; NTP = National Toxicology Program; USEPA = United States Environmental 
Protection Agency.
*Note: The listed cancer designations were based on data from nondermal (such as oral or inhalation) exposure rather than der-
mal exposure.
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guinea pig maximization test (GPMT) 
when the chemical was tested at sensitiza-
tion and challenge concentrations of 10%. 
DEREK™ does not predict EE to be a 
skin sensitizer. Therefore, on account of 
the data for this assessment, EE is not as-
signed the SK: SEN notation.
5 Summary
The available toxicokinetic data demon-
strate that EE is dermally absorbed in hu-
mans and animals following both in vitro 
and in vivo exposure, although the extent 
of absorption is lesser in humans than in 
animals. Available data indicate that EE is 
absorbed, systemically available, and poten-
tially toxic. In particular, the reviewed stud-
ies provide sufficient evidence to determine 
that EE may cause teratogenic, develop-
mental, and reproductive effects following 
repeated skin contact [Hardin et al. 1982, 
1984; Ryan et al. 1988]. The substance is 
not identified as a skin irritant or sensitizer 
in humans or animals. Therefore, on the ba-
sis of these assessments, EE is assigned a 
composite skin notation of SK: SYS. 
Table 3 summarizes the skin hazard des-
ignations for EE previously issued by 
NIOSH and other organizations. The 
equivalent dermal designation for EE, ac-
cording to the Globally Harmonized Sys-
tem (GHS) of Classification and Labeling 
of Chemicals, is Acute Toxicity Category 
4 (Hazard statement: Harmful in contact 
with the skin). EE has been identified as a 
Category 1B Reproductive toxicant (Haz-
ard statements: May damage fertility; May 
damage the unborn child) [European Par-
liament 2008].
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and (3) evaluating whether the substance 
poses a skin exposure hazard.
The algorithm is flexible in the data re-
quirement and can operate entirely on the 
basis of the physicochemical properties 
of a substance and the relevant exposure 
parameters. Thus, the algorithm is inde-
pendent of the need for biologic data. Al-
ternatively, it can function with both the 
physicochemical properties and the ex-
perimentally determined permeation co-
efficient when such data are available and 
appropriate for use.
The first step in the evaluation is to deter-
mine the Kp for the substance to describe 
the transdermal penetration rate of the 
substance [NIOSH 2009]. The Kp, which 
represents the overall diffusion of the sub-
stance through the stratum corneum and 
into the blood capillaries of the dermis, is 
estimated from the compound’s molecular 
weight (MW) and base-10 logarithm of 
its octanol–water partition coefficient (log 
KOW). In this example, Kp is determined 
for a substance with use of Equation 1. A 
self-consistent set of units must be used, 
such as cm/hr, outlined in Table A1. Oth-
er model-based estimates of Kp may also 
be used [NIOSH 2009].
Equation 1: Calculation of Skin Permeation 
Coefficient (Kp)
where Kpsc is the permeation coefficient 
in the lipid fraction of the stratum cor-
neum, Kpol is the coefficient in the protein 
This appendix presents an overview of the 
SI ratio and a summary of the calculation 
of the SI ratio for EE. Although the SI 
ratio is considered in the determination of 
a substance’s hazard potential following 
skin contact, it is intended only to serve as 
supportive data during the assignment of 
the NIOSH SK. An in-depth discussion 
on the rationale and calculation of the SI 
ratio can be found in Appendix B of the 
Current Intelligence Bulletin (CIB) 61: A 
Strategy for Assigning New NIOSH Skin 
Notations [NIOSH 2009]. 
Overview 
The SI ratio is a predictive algorithm for 
estimating and evaluating the health haz-
ards of skin exposure to substances. The al-
gorithm is designed to evaluate the poten-
tial for a substance to penetrate the skin 
and induce systemic toxicity [NIOSH 
2009]. The goals for incorporating this 
algorithm into the proposed strategy for 
assigning the SYS notation are as follows:
1. Provide an alternative method to 
evaluate substances for which no 
clinical reports or animal toxicity 
studies exist or for which empirical 
data are insufficient to determine 
systemic effects.
2. Use the algorithm evaluation re-
sults to determine whether a sub-
stance poses a skin absorption haz-
ard and should be labeled with the 
SYS notation.
The algorithm evaluation includes three 
steps: (1) determining a skin permeation 
coefficient (Kp) for the substance of in-
terest, (2) estimating substance uptake by 
the skin and respiratory absorption routes, 
Appendix: Calculation of the SI Ratio for EE
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Table A1. Summary of data used to calculate the SI ratio for EE 
Variables used in calculation Units Value
Skin permeation coefficient
Permeation coefficient of stratum corneum lipid path(Kpsc) cm/hr 0.00061
Permeation coefficient of the protein fraction of the 
stratum corneum (Kpol)
cm/hr 1.6001 × 10-5
Permeation coefficient of the watery epidermal layer (Kaq) cm/hr 0.26335
Molecular weight (MW)* amu 90
Base-10 logarithm of its octanol–water partition 
coefficient (log KOW)*
None -0.32
Calculated skin permeation coefficient (Kp) cm/hr 0.00062
Skin dose
Water solubility (SW)* mg/cm3 1000
Calculated skin permeation coefficient (Kp) cm/hr 0.00062
Estimated skin surface area (palms of hand) cm2 360
Exposure time hr 8
Calculated skin dose mg 1790.93
Inhalation dose
Occupational exposure limit (OEL)† mg/m3 1.8
Inhalation volume m3 10
Retention factor (RF) None 0.75
Inhalation dose mg 14
Skin dose–to–inhalation dose (SI) ratio None 132.66
*Variables identified from SRC [2009].
†The OEL used in calculation of the SI ratio was the NIOSH-recommended exposure limit (REL) [NIOSH 2005].
fraction of the stratum corneum, and Kaq 
is the coefficient in the watery epidermal 
layer. These components are individually 
estimated by
log Kpsc = −1.326 + 0.6097 × log KOW − 
0.1786 × MW0.5
Kpol = 0.0001519 × MW−0.5
Kaq = 2.5 × MW−0.5
The second step is to calculate the biologic 
mass uptake of the substance from skin 
absorption (skin dose) and inhalation (in-
halation dose) during the same period of 
exposure. The skin dose is calculated as a 
mathematical product of the Kp, the water 
solubility (SW) of the substance, the exposed 
skin surface area, and the duration of ex-
posure. Its units are milligrams (mg). As-
sume that the skin exposure continues for 
8 hours to unprotected skin on the palms 
of both hands (a surface area of 360 cm2). 
Equation 2: Determination of Skin Dose 
Skin dose = Kp × SW × Exposed skin sur-
face area × Exposure time
= Kp(cm/hr) × SW (mg/cm3) × 
360 cm2 × 8 hours
The inhalation dose (in mg) is derived 
on the basis of the occupational exposure 
limit (OEL) of the substance—if the OEL 
is developed to prevent the occurrence of 
Skin Notation Profiles | 2-Ethoxyethanol (EE) 11
2-Ethoxyethanol (EE)
systemic effects rather than sensory/irri-
tant effects or direct effects on the respira-
tory tract. Assume a continuous exposure 
of 8 hours, an inhalation volume of 10 cu-
bic meters (m3) inhaled air in 8 hours, and a 
factor of 75% for retention of the airborne 
substance in the lungs during respiration 
(retention factor, or RF).
Equation 3: Determination of Inhalation Dose
Inhalation dose = OEL × Inhalation 
 volume × RF
= OEL (mg/m3) × 10 m3 
× 0.75
The final step is to compare the calculated 
skin and inhalation doses and to present 
the result as a ratio of skin dose to inhala-
tion dose (the SI ratio). This ratio quantita-
tively indicates (1) the significance of der-
mal absorption as a route of occupational 
exposure to the substance and (2) the con-
tribution of dermal uptake to systemic tox-
icity. If a substance has an SI ratio greater 
than or equal to 0.1, it is considered a skin 
absorption hazard.
Calculation 
Table A1 summarizes the data applied in 
the previously described equations to de-
termine the SI ratio for EE. The calculated 
SI ratio was 132.66. On the basis of these 
results, EE is predicted to represent a skin 
absorption hazard.
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